Given that the abnormal expression of HCN4 in Rheb S16H mutant neurons is an mTORC1-dependent process (rapamycin treatment eliminated aberrant HCN4 expression) that can modulate epilepsy, it would be important to examine whether this phenotype is conserved across the different gene variants. The gene discussed is HCN4; the disease is epilepsy.